Page 72 - THE EVOLUTION OF EARLY ARTHRITIS AND CARDIOVASCULAR RISK Samina A. Turk

CHAPTER 3
82. Pedersen M, Jacobsen S, Garred P, Madsen HO, Klarlund M, Svejgaard A, et al. Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case-control study in Denmark. Arthritis and rheumatism 2007;56(5):1446-1453.
83. Sparks JA, Iversen MD, Miller Kroouze R, Mahmoud TG, Triedman NA, Kalia SS, et al. Personalized Risk Estimator for Rheumatoid Arthritis (PRE-RA) Family Study: rationale and design for a randomized controlled trial evaluating rheumatoid arthritis risk education to first-degree relatives. Contemporary clinical trials 2014;39(1):145-157.
84. KarlsonEW,ShadickNA,CookNR,BuringJE,LeeIM.VitaminEintheprimaryprevention of rheumatoid arthritis: the Women’s Health Study. Arthritis and rheumatism. 2008;59(11):1589-1595.
85. Bos WH, Dijkmans BA, Boers M, van de Stadt RJ, van Schaardenburg D. Effect of dexamethasone on autoantibody levels and arthritis development in patients with arthralgia: a randomised trial. Annals of the rheumatic diseases 2010;69(3):571-574.
86. Gonzalez-Lopez L, Gamez-Nava JI, Jhangri GS, Ramos-Remus C, Russell AS, Suarez- Almazor ME. Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism. The Journal of rheumatology 1999;26(3):540-545.
87. Gonzalez-Lopez L, Gamez-Nava JI, Jhangri G, Russell AS, Suarez-Almazor ME. Decreased progression to rheumatoid arthritis or other connective tissue diseases in patients with palindromic rheumatism treated with antimalarials. The Journal of rheumatology 2000;27(1):41-46.
88. Youssef W, Yan A, Russell AS. Palindromic rheumatism: a response to chloroquine. The Journal of rheumatology. 1991;18(1):35-37.
89. vanDongenH,vanAkenJ,LardLR,VisserK,RondayHK,HulsmansHM,etal.Efficacyof methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis and rheumatism 2007;56(5):1424-1432.
90. Marzo-Ortega H, Green MJ, Keenan AM, Wakefield RJ, Proudman S, Emery P. A randomized controlled trial of early intervention with intraarticular corticosteroids followed by sulfasalazine versus conservative treatment in early oligoarthritis. Arthritis and rheumatism 2007;57(1):154-160.
91. Verstappen SM, McCoy MJ, Roberts C, Dale NE, Hassell AB, Symmons DP. Beneficial effects of a 3-week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: results of the STIVEA trial. Annals of the rheumatic diseases 2010;69(3):503-509.
92. Machold KP, Landewe R, Smolen JS, Stamm TA, van der Heijde DM, Verpoort KN, et al. The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis. Annals of the rheumatic diseases 2010;69(3):495-502.
93. SaleemB,MackieS,QuinnM,NizamS,HensorE,JarrettS,etal.Doestheuseoftumour necrosis factor antagonist therapy in poor prognosis, undifferentiated arthritis prevent progression to rheumatoid arthritis? Annals of the rheumatic diseases 2008;67(8):1178- 1180.
70